I think value investors should like at least one biotech stock: BioNTech (NASDAQ: BNTX). You can scoop up a share of BioNTech for less than $120 at the time of this writing. This German biotech ...

Novartis agreed late Monday to buy German drugmaker MorphoSys for roughly $2.9 billion, and the biotech stock catapulted to a nearly three-year high. Please watch the video at Investors.com ...

GILD entered into an exclusive option and license agreement with Tubulis, a Germany-based biotech company ... team of experts has just released the 5 stocks with the greatest probability of ...

Additionally, Novartis (NYSE:NVS) just bought German biotech MorphoSys for $2.9 billion. If you’re looking for the next potential buyout among biotech stocks, examine these three. The last time ...

Based on its preliminary unaudited consolidated figures, BB Biotech AG reports a profit of approximately CHF 76 million for the financial year 2024 (loss of CHF 207 million in the previous year). For ...